Analyst Downgrades – MNLO – Menlo Therapeutics (NASDAQ:MNLO) Stock Gets Downgraded By Jefferies Group from Buy to Hold

Analyst Ratings For MNLO – Menlo Therapeutics (NASDAQ:MNLO)

Story continues below

Today, MNLO – Menlo Therapeutics (NASDAQ:MNLO) stock was downgraded by Jefferies Group from Buy to Hold.

Some recent analyst ratings include

  • 4/9/2018-Jefferies Group was Downgraded by analysts at Jefferies Group from a “Buy ” rating to a ” Hold” rating.
  • 2/20/2018-JMP Securities initiated coverage with a Mkt Outperform rating.
  • 2/20/2018-Piper Jaffray initiated coverage with a Overweight rating.
  • 2/19/2018-Guggenheim initiated coverage with a Buy rating.


    Recent Trading Activity for MNLO – Menlo Therapeutics (NASDAQ:MNLO)
    Shares of MNLO – Menlo Therapeutics closed the previous trading session at 10.21 down -25.01 71.01% with shares trading hands.

    An ad to help with our costs